top of page
630cb0657ed27f158401e7d5_university-hospital-wound-care-clinic-250-1600x732_edited.jpg

Our PRODUCTS

Healing Innovation, Transforming Wounds into Wellness

FEATURED PRODUCTS

Zenith™

Single-Layer Amniotic Graft | Q4253

Zenith Single-Layer Amniotic Graft is a sterile allograft designed for optimal wound covering and protection during the treatment of wounds.

Key Features and Properties

  • Provides a reliable protective wound covering backed by decades of science  

  • Dehydrated extracellular matrix acts as a scaffold supporting the native tissue

  • Adheres easily to wounds including those with irregular surfaces

  • 5-year shelf life at ambient temperature storage

wound care at home
homecare services

Zenith Ordering Information

Wound care

Zenith Single-Layer Amniotic Graft is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. Zenith Single-Layer Amniotic Graft is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. Zenith Single-Layer Amniotic Graft is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Advanced wound healing
Chronic wound treatment

Impax™

Dual-Layer Amniotic Graft

Awarded Q Code Q4262

Impax Dual-Layer Amniotic Graft is a sterile allograft designed for optimal wound covering and protection during the treatment of wounds.

Key Features and Properties

  • Provides a protective wound covering

  • Dehydrated extracellular matrix acts as a scaffold supporting the native tissue

  • Adheres easily to wounds, including those with irregular surfaces

  • 5-year shelf life at ambient temperature storage

Impax Ordering Information

Wound care products

Impax Dual-Layer Amniotic Graft is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. Impax Dual-Layer Amniotic Graft is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. Impax Dual-Layer Amniotic Graft is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Orion™

Dual-Layer Allograft

Awarded Q Code Q4276

Orion Dual-Layer Allograft is a sterile dual layer allograft designed for optimal wound covering and protection during the treatment of wounds.

Key Features and Properties

  • Provides a protective wound covering

  • Dehydrated extracellular matrix acts as a scaffold supporting the native tissue

  • Adheres easily to wounds, including those with irregular surfaces

  • 5-year shelf life at ambient temperature storage

Diabetic wound care
Pressure ulcer prevention

Orion Ordering Information

Wound management

Orion Dual-Layer Allograft is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. Orion Dual-Layer Allograft is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. Orion Dual-Layer Allograft is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Surgical wound care
Infected wound treatment

SurGraft FT™

Full-Thickness Graft

Awarded Q Code Q4268

SurGraft FT is a sterile full-thickness graft designed for optimal wound covering and protection during the treatment of wounds.

Key Features and Properties

  • Provides a reliable protective wound covering backed by decades of science

  • Dehydrated extracellular matrix acts as a scaffold supporting the native tissue

  • Adheres easily to wounds including those with irregular surfaces

  • 5-year shelf life at ambient temperature storage

SurGraft FT Ordering Information

Non-healing wound solutions

SurGraft FT full thickness graft is an allograft derived from a prescreened mother with a planned C-section delivery. SurGraft FT is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. SurGraft FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

bottom of page